This inventor holds 6 USPTO granted patents and 5 published patent applications. Top assignee: University Health Network. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Kenji Murata: Innovator in T Cell Receptor Technology
Introduction
Kenji Murata is a prominent inventor based in Toronto, Canada. He has made significant contributions to the field of immunology, particularly in the development of T cell receptors. With a total of 6 patents to his name, Murata's work has the potential to impact therapeutic strategies for various diseases.
Latest Patents
Among his latest innovations, Murata has focused on T cell receptors and methods of use thereof. These patents represent cutting-edge advancements in the understanding and application of T cell technology in medical treatments.
Career Highlights
Kenji Murata is affiliated with the University Health Network, where he continues to push the boundaries of research in immunology. His work is characterized by a commitment to improving health outcomes through innovative scientific solutions.
Collaborations
Murata has collaborated with notable colleagues, including Naoto Hirano and Munehide Nakatsugawa. These partnerships have fostered a collaborative environment that enhances the research and development of new technologies.
Conclusion
Kenji Murata's contributions to the field of T cell receptor technology exemplify the spirit of innovation in modern science. His work not only advances our understanding of immunology but also holds promise for future medical breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
